Risteys ·

Coding

Definition

OMOP Concept ID: 3032333— open in OHDSI Athena.
Part of collection: Phosphate with 2 other OMOP concepts — open in OHDSI Athena.

OMOP mapping QC

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3032333	du-pi	— (—)	104	117	100.00%	Distribution not available

Cohort

Number of people: 107 (51.40% female)

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

No data available for the duration from to last measurement distribution.

Statistics

People with ≥2 records: 6.54%
Median number of measurements per person: 1.0
Median duration from first to last measurement: 0.77 years

Number of measurements over the years

Number of measurements per person

Distribution of lab values

No data available for the lab value distribution.

Reference range

N people

N records

—

20-50/KAIKKI

20-50/kaikki

Value range per person

No data available for the distribution of value range per person.

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Disorders of phosphorus metabolism and phosphatases

+∞

14.80

1.6

0.0

—

Genitourinary diseases

6.86

12.26

1.0

1.3

—

Chronic kidney disease

9.05

8.04

1.1

1.0

—

Unspecified haematuria

4.90

7.11

1.0

1.2

—

Disorder of mineral metabolism, other/unspecified

+∞

6.32

1.0

0.0

—

Secondary hypertension

17.87

6.23

1.0

—

Gout, strict definition

10.01

4.01

1.0

1.1

—

Osteoporosis

9.54

3.39

1.0

1.2

—

Gout, unspecified

7.00

3.36

1.0

1.1

—

Gout, idiopatic and unspecified

7.00

3.36

1.0

1.1

—

ILD medications: azathioprine

5.72

3.34

1.0

1.4

—

Azathioprine

5.34

3.19

1.0

1.3

—

Chronic rhinitis, nasopharyngitis and pharyngitis

3.45

3.04

1.0

1.2

—

Gout, FINNGEN

5.84

3.02

1.0

—

Other CVD

10.00

2.98

1.6

1.0

—

Nephropathy related operations

8.34

2.75

1.0

1.2

—

Dialysis, with operation codes

8.34

2.75

1.0

—

Erosion of teeth, including avohilmo

4.07

2.59

1.9

1.2

—

Perforation of tympanic membrane

7.15

2.55

1.0

1.1

—

Glomerular disorders in diseases classified elsewhere

7.15

2.55

1.0

1.1

—

Irritable bowel syndrome

3.46

2.48

1.2

—

Gout

3.75

2.15

1.0

1.1

—

Dentinal caries

3.67

2.14

1.7

1.1

—

Dental caries

3.47

2.03

1.7

1.1

—

Chronic periodontitis

4.55

1.94

2.4

1.1

—

Other diseases of lip and oral mucosa

4.17

1.82

1.0

1.1

—

Acetic acid derivatives and related substances

3.47

1.63

1.2

1.0

—

Nausea and vomiting

3.28

1.50

1.2

1.0

—

Other menopausal disorders

3.60

1.49

1.0

—

Migraine without aura

3.13

1.44

1.0

1.3

—

Epilepsy

2.49

1.30

1.2

—

Dental pulpitis 3, only avohilmo

2.44

1.22

2.2

1.1

—

Dental pulpitis 3

2.40

1.20

2.2

1.1

—

Retention of urine

2.64

1.20

1.4

1.1

—

Deviated nasal septum

2.14

0.91

1.0

1.2

—

Peritonsillar abscess

2.08

0.74

1.0

1.3

—

5-aminosalicylic acid

2.00

0.72

1.2

—

Childhood allergy (age < 16)

1.96

0.71

1.0

1.4

—

Acute alcohol intoxication, ICD10

1.85

0.68

1.0

1.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1.72

0.63

1.0

1.1

—

Factors influencing health status and contact with health services

1.88

0.61

1.2

1.0

—

Single delivery by forceps and vacuum extractor

0.00

0.60

0.0

1.1

—

Procreative management

1.49

0.51

1.0

1.2

—

Heart failure and coronary heart disease

0.00

0.42

0.0

1.0

—

Coronary artery bypass grafting

0.00

0.41

0.0

1.0

—

Type1 diabetes, definitions combined, early onset

0.00

0.41

0.0

1.3

—

Injury of muscle and tendon at wrist and hand level

0.00

0.40

0.0

1.4

—

Other condition

0.00

0.40

0.0

1.4

—

Certain conditions originating in the perinatal period

0.00

0.40

0.0

1.3

—

Diseases of male genital organs

1.20

0.25

1.0

1.2

—

Other functional intestinal disorders

1.29

0.23

1.4

1.1

—

Postmenopausal bleeding

0.00

0.22

0.0

1.0

—

Other sexually transmitted chlamydial diseases

0.00

0.21

0.0

1.0

—

Social phobias

0.00

0.21

0.0

1.5

—

Colorectal cancer

0.00

0.21

0.0

1.1

—

Pedal cyclist injured in other and unspecified transport accidents

0.00

0.21

0.0

1.5

—

Non-ischemic cardiomyopathy

0.00

0.21

0.0

1.0

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

0.21

0.0

1.5

—

Acute bronchiolitis

0.00

0.21

0.0

1.4

—

Other disorders of penis

0.00

0.20

0.0

1.4

—

Type 1 diabetes, strict definition, subgroup 1

0.00

0.20

0.0

1.4

—

Type 1 diabetes, strict definition

0.00

0.20

0.0

1.4

—

Persons encountering health services in circumstances related to reproduction

1.02

0.07

1.0

1.2

—

ILD, hospital admissions

0.00

0.0

1.2

—

Congenital malformations of eye, ear, face and neck

0.00

0.0

1.1

—

Chronic suppurative otitis media

0.00

0.0

1.2

—

Purpura and other haemorrhagic conditions

0.00

0.0

1.1

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

0.00

0.0

1.1

—

Retinal detachment with retinal break

0.00

0.0

1.2

—

Injuries to unspecified part of trunk, limb or body region

0.00

0.0

1.2

—

Multiple delivery

0.00

0.0

1.0

—

Malignant neoplasm of colon

0.00

0.0

1.2

—

Injury of unspecified body region

0.00

0.0

1.2

—

Event of undetermined intent

0.00

0.0

1.2

—

Foreign body or object entering through skin

0.00

0.0

1.2

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Recurrent dislocation of patella

0.00

0.0

1.0

—

Aortic valve malfunction, age under 60 years

0.00

0.0

1.1

—

Adjustment and management of implanted device

0.00

0.0

1.0

—

Mixed specific developmental disorders

0.00

0.0

1.7

—

Malignant neoplasm of bronchus and lung

0.00

0.0

1.2

—

Varicose veins of other sites

0.00

0.0

1.0

—

Other viral hepatitis

0.00

0.0

1.0

—

Other and unspecified local infections of skin and subcutaneous tissue

0.00

0.0

1.2

—

Other congenital malformations of the digestive system

0.00

0.0

1.9

—

Viral hepatitis

0.00

0.0

1.1

—

Use of rivastigmine

0.00

0.0

1.2

—

Other local infections of skin and subcutaneous tissue

0.00

0.0

1.2

—

Colorectal adenocarcinoma

0.00

0.0

1.1

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

Diseases of the myoneural junction and muscle

0.00

0.0

1.1

—

Etanercept

0.00

0.0

1.2

—

Hypoglycaemia, other or unspecified

0.00

0.0

1.2

—

Mental and behavioural disorders due to cannabinoids

0.00

0.0

1.6

—

Undefined dementia

0.00

0.0

1.2

—

Obsessive-compulsive disorder

0.00

0.0

1.6

—

Other disorders of glucose regulation and pancreatic internal secretion

0.00

0.0

1.2

—

Chronic viral hepatitis

0.00

0.0

1.0

—

Conductive hearing loss, unspecified

0.00

0.0

1.2

—

Chronic suppurative otitis media, including avohilmo

0.00

0.0

1.2

—

Open bite

0.00

0.0

1.0

—

Wide developmental disorders

0.00

0.0

1.7

—

Lung cancer and mesothelioma

0.00

0.0

1.0

—

Other bursopathies

0.00

0.0

1.1

—

Postmenopausal atrophic vaginitis

0.00

0.0

1.0

—

Other disorders of male genital organs

0.00

0.0

1.8

—

Colectomy operation

0.00

0.0

1.2

—

Other/unspecified reactive arthropathies

0.00

0.0

1.2

—

Benign neoplasm: Ascending colon

0.00

0.0

1.2

—

Maltreatment syndromes

0.00

0.0

1.0

—

Pedestrian injured in transport accident

0.00

0.0

1.2

—

Contact with other sharp object(s)

0.00

0.0

1.9

—

Parkinson's disease, strict definition, excluding more controls

0.00

0.0

1.0

—

Autism spe, excluding more controls

0.00

0.0

1.7

—

Other specified/unspecified inflammatory spondylopathies

0.00

0.0

1.2

—

Schizoaffective disorder

0.00

0.0

1.9

—

Wide developmental disorders, excluding more controls

0.00

0.0

1.6

—

Other interstitial pulmonary diseases

0.00

0.0

1.2

—

Cardiomyopathies, Primary/intrinsic

0.00

0.0

1.0

—

Interstitial lung disease

0.00

0.0

1.2

—

Other inflammation of eyelid

0.00

0.0

1.2

—

Non-small cell lung cancer

0.00

0.0

1.2

—

Mandibular retrognathia

0.00

0.0

1.1

—

Malignant neoplasm of respiratory system and intrathoracic organs

0.00

0.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of elbow

0.00

0.0

1.1

—

Inflammatory diseases of the central nervous system

0.00

0.0

1.2

—

Autism

0.00

0.0

2.0

—

Mixed and other personality disorders

0.00

0.0

1.1

—

Mental retardation, excluding more controls

0.00

0.0

1.2

—

Other and unspecified tonsillitis

0.88

0.00

1.0

1.2

—

Acute lymphadenitis

0.00

0.0

1.2

—

Cardiomyopathy (excluding other)

0.00

0.0

1.0

—

Hypermetropia

0.00

0.0

1.1

—

Intermittent heterotropia

0.00

0.0

1.9

—

Polyarthrosis

0.00

0.0

1.0

—

Persistent delusional disorders

0.00

0.0

1.1

—

Retinal breaks without detachment

0.00

0.0

1.2

—

Other disorders of cornea

0.00

0.0

1.2

—

Interstitial lung disease endpoints

0.00

0.0

1.2

—

Suggestive for eosinophilic asthma

0.00

0.0

1.2

—

Other hammer toe(s) (acquired)

0.00

0.0

1.0

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

0.00

0.0

1.1

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

0.00

0.0

1.0

—

AV-block

0.00

0.0

1.0

—

Other respiratory diseases principally affecting the interstitium

0.00

0.0

1.2

—

Mental and behavioural disorders due to opioids

0.00

-0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Phosphate [Mass or Moles] in 24 hour Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS